CUTISS Stock
Developer of personalized bio-engineered skin grafts designed to treat large skin defects. By combining a patient’s cells with a hydrogel, the grafts generate dermo-epidermal skin, reducing the need for autografting and corrective procedures. This approach lowers costs while enhancing recovery and quality of life.
Founded: 2015
For more CUTISS stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Dr. Daniela Marino Co-Founder & Chief Executive Officer |
| Dr. Vincent Ronfard Chief Innovation Officer |
| Kathi Mujynya Ludunge Chief Operating Officer |
